Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States.
Corcept Therapeutics stock last closed at $57.59, down 0.71% from the previous day, and has increased 135.93% in one year. It has overperformed other stocks in the Biotechnology industry by 2.17 percentage points. Corcept Therapeutics stock is currently +176.34% from its 52-week low of $20.84, and -23.21% from its 52-week high of $75.00.
At the moment, there are 105.5M CORT shares outstanding. The market value of CORT is $6.08B. In the last 24 hours, 882,520 CORT shares were traded.
How to Buy Corcept Therapeutics Stock
Not sure how to invest in Corcept Therapeutics stock? Here's how.
Figure out where to buy Corcept Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Corcept Therapeutics stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Pick your method of payment and add your info.
Evaluate Corcept Therapeutics stock: The Corcept Therapeutics ticker symbol is CORT. Is Corcept Therapeutics stock a good investment? Should you buy shares of CORT? How do CORT's underlying business fundamentals look? Do top analysts think Corcept Therapeutics is a good buy? Why has CORT's stock price moved recently? (Hint: Our stock market research website can help you evaluate if CORT is a good stock to buy).
Execute your CORT buy order: Decide if you will purchase CORT shares at the current market price or use a limit order to purchase CORT stock at a specific price.
Watch your CORT investment: Create a watchlist to get the latest news on your new investment in Corcept Therapeutics shares.
Step 1: Figure out where to buy Corcept Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy CORT shares.
A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you can invest in CORT today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Corcept Therapeutics stock
Once you have identified the best place to buy Corcept Therapeutics stock, it's important to research their stock before you invest, so you actually wrap your head around the risk and upside.
Corcept Therapeutics Numbers
CORT Price
$57.59
1w %
5%
1y %
135.93%
5y %
461.31%
P/E
42.66x
P/B
8.94x
P/S
8.81x
PEG
0.82x
Revenue
$675.04M
Earnings
$139.73M
Fore. Rev. Growth
25.92%
Fore. Earn. Growth
51.85%
Market Cap
$6.08B
Next Earnings
Apr 29, 2025
Next Dividend
N/A
Fundamentals of CORT
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in less time.
Last year, CORT earnings were $139.73M. Over the last five year, CORT's earnings have gone up by 10.49% per year. This was slower than the Biotechnology industry average of 11.39%.
Last year, CORT revenue was $675.04M. During the last 5 year, CORT's revenue has gone up by 17.11% per year. This was slower than the Biotechnology industry average of 45.76%.
No, Corcept Therapeutics doesn't provide an income stream by paying out dividends.
CORT Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your CORT buy order
There are two primary options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly fine.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you need additional assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Corcept Therapeutics share?
As of Mar 20, 2025, it costs $57.59 to buy one share of Corcept Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.174 shares of CORT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.